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Over the past years, echocardiography has been
shown to play a pivotal role in the accurate evaluation
of left ventricular function particularly in patients
with ischemic heart disease and various manifesta-
tions of cardiomyopathy [1]. The ability to rapidly
perform bedside echocardiography with Echo-
Doppler imaging places this modality in the heart
of clinical research to understand cardiac function
and to quantify various associated abnormalities.
Echocardiography has found a major niche in visu-
alizing left ventricular function in diverse manifes-
tions of cardiomyopathies. For instance, widespread
use of echocardiography has contributed to more
frequent recognition of takotsubo stress cardiomyop-
athy [1–3]. Takotsubo cardiomyopathy has recently
been recognized in patients with typical signs of
acute myocardial infarction mostly due to emotional
stress [4]. The disease may mimic an acute coronary
syndrome and the acute course can be complicated by
heart failure, arrhythmias, dynamic left ventricular
outﬂow tract obstruction, hypotension and death [5].
In these patients the coronary arteries appear normal
but they show reversible wall motion abnormalities
[6, 7].
In the current issue of the International Journal of
Cardiovascular Imaging, Chockaligam et al. [8]
nicely reviewed the clinical presentation of takotsubo
stress cardiomyopathy and proposed a uniﬁed diag-
nostic algorithm for cardiologists acutely managing
this cardiac emergency. Also the pivotal role of
echocardiography was emphasized and the nuances
of this peculiar acute cardiomyopathy from an echo-
cardiographers’ perspective were put forward. Accu-
rate evaluation by echocardiography may assist in
reﬁning the diagnosis of takotsubo cardiomyopathy
and to unravel its pathophysiological mechanism. The
diagnosis of stress cardiomyopathy appears appropriate
when angiography reveals no culprit lesions and left
ventricular apical ballooning is typically seen. For
example, at ﬁrst sight, stress cardiomyopathy appears
like an evolving left anterior descending infarction
with akinesia of the apex, apical anterior wall and
septum. At a closer view of the two-dimensional
images from the apical four- and two chamber views,
typical stress cardiomyopathy manifests as symmet-
rical regional wall motion abnormalities extending
equally into the apical inferior and lateral walls.
However, the deﬁnitive diagnosis of stress cardio-
myopathy is conﬁrmed when echocardiography
repeated after few days to weeks shows complete
normalization of regional wall motion abnormalities
and left ventricular ejection fraction. Interestingly,
the authors also revealed that about 25% of patients
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ventricular outﬂow tract obstruction. Loading condi-
tions may signiﬁcantly alter the severity of left
ventricular outﬂow tract obstruction which may be a
transient phenomenon. Left ventricular outﬂow tract
obstruction can be precipitated when a small left
ventricle develops hypercontractility, especially in
the basal segments. This may lead to acute systolic
subendocardial wall stress. This left ventricular strain
consisting of both the systolic blood pressure and
increased wall stress may result in myocardial
stunning and cause the acute ballooning syndrome.
Also advanced echocardiographic techniques such as
tissue Doppler imaging, regional strain imaging and
time-volume curves from three-dimensional echo
image modeling may offer visually better demon-
stration of the regional wall motion abnormalities of
stress cardiomyopathy with higher diagnostic sensi-
tivity. Lastly, transesophageal echocardiography may
provide anatomic details that may direct repair or
replacement of the mitral apparatus when signiﬁcant
MR persists after stress cardiomyopathy and left
ventricular outﬂow tract obstruction have resolved.
As also mentioned by the authors, magnetic
resonance imaging (MRI) has become an important
imaging modality in patients with a broad spectrum
of cardiomyopathies [2, 9–56], in particular in
patients with takotsubo cardiomyopathy [57–61]. In
a recent study, the value of MRI has been shown by
using its capability of myocardial tissue character-
ization [57]. At coronary angiography all patients
showed normal coronary arteries; four patients had
apical ballooning and four patients had midwall- or
basal ballooning. MRI was performed at hospital
admission and the images were analyzed with
commercially available software (QMASS MR Ver-
sion 6.2.1, Medis, Leiden, the Netherlands). A T2-
weighted imaging technique was used and it was
found that T2-signal intensity was signiﬁcantly
higher in the dysfunctional segments, potentially
indicating the presence of myocardial edema in the
affected areas that showed ballooning. In the ﬁve
patients who had a 2–3 week follow-up MRI scan,
there was normalization of the wall motion abnor-
malities associated with a signiﬁcant reduction in T2
signal intensity. As a result, it might be of great
interest to know the pathophysiological condition of
the affected myocardial tissue in the setting of the
acute myocardial infarction in patients with stress
cardiomyopathy. Both echocardiography- and MRI-
derived parameters may therefore be of great signif-
icance in the follow-up of these patients as they
may show spontaneous recovery of the cardiac
abnormalities.
To summarize, both echocardiography and MRI
have their own speciﬁc value in the evaluation of
patients with takotsubo cardiomyopathy. Of course,
echocardiography, by virtue of its versatility and
accessibility, wlll remain the ﬁrst imaging modality
of choice in routine clinical practice.
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